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NGF-Induced Axon Growth Is Mediated by
Localized Inactivation of GSK-3 and Functions
of the Microtubule Plus End Binding Protein APC
assembly of cytoskeletal proteins into axons. The impor-
tance of such local signaling was established by studies
more than two decades ago in which neuron cell bodies
were separated from their axons (Campenot, 1982a,
1982b). These “Campenot Chamber” studies demon-
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strated that NGF-activated gene expression in the cell2BC Cancer Agency
bodies alone was not sufficient to support axon growthJack Bell Research Centre
into the side compartment. The presence of NGF in theVancouver, British Columbia V6H 3Z6
axon compartment is absolutely required. Despite theCanada
fact that neurotrophin signaling has been the subject of
numerous investigations during the past two decades,
surprisingly little is known about how this local signalingSummary
regulates the cytoskeleton to form the axon.
There is mounting evidence that PI3K is involved inLittle is known about how nerve growth factor (NGF)
local signaling underlying several aspects of neuro-signaling controls the regulated assembly of micro-
trophin-mediated axon morphogenesis, including elon-tubules that underlies axon growth. Here we demon-
gation and guidance. Thus, pharmacological studies instrate that a tightly regulated and localized activation
compartmentalized cultures have established that PI3Kof phosphatidylinositol 3-kinase (PI3K) at the growth
signaling is required for axon growth into an NGF-con-cone is essential for rapid axon growth induced by
taining side chamber (Atwal et al., 2000). ExperimentalNGF. This spatially activated PI3K signaling is con-
evidence also implicates local PI3K signaling in mediat-veyed downstream through a localized inactivation of
ing the turning and branching effects of neurotrophinsglycogen synthase kinase 3 (GSK-3). These two
applied locally at the growth cone or axon shaft (Gallospatially coupled kinases control axon growth via reg-
and Letourneau, 1998; Ming et al., 1999). A number ofulation of a microtubule plus end binding protein, ade-
signaling molecules, such as Akt, integrin-linked kinasenomatous polyposis coli (APC). Our results demon-
(ILK), and GSK-3, with potential to regulate the cyto-strate that NGF signals are transduced to the axon
skeleton are established as downstream mediators ofcytoskeleton via activation of a conserved cell polarity
PI3K in neurons and nonneuronal cells (reviewed bysignaling pathway.
Cantley, 2002). Furthermore, in nonneuronal cells, it is
well established that PI3K signaling regulates actin dy-Introduction
namics through the regulation of Rac (Reif et al., 1996).
To date, however, the mechanisms by which PI3K regu-Axon morphogenesis, including outgrowth, guidance,
lates axon elongation are unclear.and preterminal branching, is carefully orchestrated dur-
Growth cones at the tips of growing axons are theing embryonic development to establish the correct wir-
major sites where neurons receive and integrate extra-ing of the nervous system. Signaling pathways medi-
cellular signals to direct axonal cytoskeletal assemblyating these events must ultimately converge to regulate
(see Baas and Luo, 2001, for a review). Axon elongationthe reorganization of the neuronal cytoskeleton. How-
is initiated with growth cone advancement via actin poly-ever, we still know relatively little about the linkage be-
merization at the leading edge. Subsequent microtubuletween the major signaling pathways that mediate axon
polymerization and bundling are the major events that
growth and the underlying cytoskeletal mechanisms.
mediate the formation of axons (Gordon-Weeks, 1991).
A variety of extracellular cues, including intermediate-
Although the cytoskeletal mechanisms underlying growth
and long-range target-derived factors, contribute to reg- cone motility during axon growth and guidance have
ulating axon morphologies. One such group of mole- been extensively studied, how extracellular signals con-
cules, key to the development of the axon projections trol the growth cone cytoskeleton, especially the micro-
of neurons in the peripheral nervous system (PNS), are tubules, remains a significant question (see Dent and
the neurotrophins. By binding to their specific receptor Gertler, 2003, for a review).
tyrosine kinases (TRKs), neurotrophins strongly activate A signaling mediator downstream of PI3K that could
both the MAPK and PI3K pathways in neurons (see lead to microtubule regulation is GSK-3 (Mills et al.,
Segal, 2003, for a recent review). Coordinated action 2003). GSK-3, first identified as a regulator of glycogen
of these pathways mediates the biological effects of synthesis, is now known to be involved in the signaling
neurotrophins on survival and axon growth. Neuro- pathways of insulin and growth factors acting through
trophin-stimulated axon outgrowth requires the activa- receptor tyrosine kinases. It is constitutively active in
tion of transcription factors and continuous gene ex- resting cells and must be inactivated by extracellular
pression and protein synthesis to supply raw materials signals to allow the activation of its substrates (see
for axon growth (see Markus et al., 2002a, for a review). Woodgett, 2001, and Cohen and Frame, 2001, for re-
In addition to gene expression, a local signaling pathway views). In neuronal cells, GSK-3 is inactivated by PI3K-
activated by neurotrophins is required to control the mediated phosphorylation and has been shown to affect
PI3K-mediated neuronal survival (Crowder and Free-
man, 2000; Hetman et al., 2000). GSK-3 has also been*Correspondence: william_snider@med.unc.edu
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intensively studied because of its key role in Wnt signal-
ing. In the Wnt pathway, GSK-3 forms a complex with
axin and APC, phosphorylates these substrates, and
controls gene expression by regulating -catenin levels
(see Woodgett, 2001, for a review). In addition to the
regulation of -catenin levels in the Wnt pathway, APC
has recently been shown in nonneuronal cells to bind to
the plus ends of microtubules and stabilize their growing
ends, a property that is abolished by GSK-3 phosphor-
ylation (Zumbrunn et al., 2001). APC binds to microtu-
bules with its C terminus, either directly via the basic
domain or indirectly via the EB1 binding domain (Mimori-
Kiyosue and Tsukita, 2001). Recent studies have demon-
strated the role of GSK-3-APC-microtubule interac-
tions in regulating polarized cell migration downstream
of the cdc42-par3/par6 pathway (Etienne-Manneville
and Hall, 2003). It would be interesting to test whether
this pathway plays a role in axon outgrowth, another
well-known example of cell polarization involving micro-
tubule reorganization. Indeed, APC is highly enriched in
the nervous system of both vertebrates and inverte-
brates (Akong et al., 2002; Bhat et al., 1994; Brakeman
et al., 1999).
In the present studies, we demonstrate that a tightly
regulated and localized activation of PI3K at the growth
cone is essential for rapid axon growth induced by NGF.
This spatially activated PI3K signaling is conveyed
downstream through a localized inactivation of GSK-
3. We further show that these two spatially coupled
kinases control axon growth by regulating a microtubule
plus end binding protein, APC. Our findings provide evi-
dence that spatially controlled signal transduction is
necessary for efficient axon elongation. Moreover, we
Figure 1. Spatially Regulated PI3K Activation at the Distal Axondefine a signaling cascade from an extracellular signal
(A) Activation of PI3K in fixed neurons was indicated by staining forto the growth cone cytoskeleton. Last, we demonstrate
phosphorylated Akt (A1). pAkt was mainly found in the cell bodythat an evolutionarily conserved pathway regulating cell
(star) and the distal tip of the axon (the growth cone, yellow arrow).
polarity also controls axon elongation induced by neuro- Little pAkt was detected along the axon shaft (white arrowheads).
trophins. High magnification showed colocalization of pAkt with actin fila-
ments (A2). Membrane accumulation of EGFP-PH-Akt was used as
another indicator of PI3K activation (A3). EGFP-PH was localizedResults
primarily in the cell body (star) and the growth cone (yellow arrow).
White arrowheads mark the axon shaft. Scale bar, 10 m in (A2)
A Spatially Regulated PI3K-GSK-3 Pathway and 30 m in (A1) and (A3).
at the Distal Axon Is Required (B) Quantification of phospho-Akt staining at axon tip versus axon
shaft. The value is expressed as a ratio of pAkt staining normalizedfor Rapid Axon Elongation
to DTAF staining as a marker for total protein at the two locations.A previous study using a dominant inhibitory PI3K con-
* Indicates significant difference from the axon shaft staining (n  3struct demonstrated that PI3K is a key signaling media-
independent experiments, p  0.01).tor that mediates NGF-induced axon growth (Markus
et al., 2002b). To study the mechanism of this PI3K
regulation, we first examined the localization of PI3K To visualize PI3K activation in real time, we trans-
fected neurons with a construct encoding the PH do-activation during NGF-mediated axon growth from em-
bryonic mouse DRG neurons. Phosphorylated Akt was main derived from Akt coupled with EGFP. Upon PI3K
activation, PH domain-containing proteins are recruitedused as a marker for PI3K activation (see Shi et al., 2003).
Our results showed localized staining of phospho-Akt to the membrane by PIP3, the lipid product of PI3K (see
Cantley, 2002, for a review). As shown in Figure 1A3,at the distal ends of the axons (Figure 1A1), demonstra-
ting a spatial distribution of activated PI3K. High-magni- EGFP-PH (Akt) was highly concentrated at the leading
edge of the growth cone (arrow), whereas little wasfication imaging showed colocaliation of phospho-Akt
with actin filaments in the growth cone (Figure 1A2). found along the axon shaft (arrowheads). This result
indicates spatially localized production of PIP3 at theQuantitation of relative average fluorescence intensity
along the axon normalized for the difference in total growth cones. Time-lapse imaging showed sustained
accumulation of EGFP-PH at the growth cone duringprotein along the axon due to variations in axonal volume
(see Experimental Procedures) verified that phospho- axon extension (data not shown).
To test whether localized activation of PI3K is neces-Akt staining was significantly higher at the growth cone
than along the axon shaft (Figure 1B). sary for axon growth induced by NGF, we overexpressed
GSK-3 and APC Mediate NGF-Induced Axon Growth
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a constitutively activated PI3K in the form of the mem- distribution. Quantitation showed that inactivated GSK-
brane-targeted chimeric protein p110-CAAX that local- 3 at the growth cone was significantly higher than in
ized along the entire axon. Control neurons expressing the axon shaft (Supplemental Figure S1C at http://www.
EGFP showed no changes in axon extension (Supple- neuron.org/cgi/content/full/42/6/897/DC1). Higher-
mental Figure S1A, top panel, arrows [available at http:// magnification imaging revealed inactivated GSK-3 in
www.neuron.org/cgi/content/full/42/6/897/DC1). In the microtubule-rich central domain of the growth cone
contrast, transfection with p110-CAAX resulted in a very and colocalization of inactivated GSK-3 with actin fila-
significant retardation of axon elongation compared to ments in the peripheral domain (Figure 2D). Similar colo-
control cells expressing EGFP (Supplemental Figures calization with actin has been reported in growth cones
S1A, lower panel, and S1B). The inhibitory effect of p110- of chicken DRG neurons (Eickholt et al., 2002) and at
CAAX on axon growth was unlikely due to the nonspe- the leading edge of migrating astrocytes (Etienne-Man-
cific effect of the CAAX motif. In our hands, EGFP-CAAX neville and Hall, 2003).
has no effect on axon growth compared to EGFP alone To show that this localized inactivation of GSK-3
(A. Markus and W.D.S., unpublished data). Furthermore, is required for axon elongation induced by NGF, we
Raf-CAAX strongly promotes rather than inhibits axon overexpressed a GSK-3 mutant that cannot be inacti-
growth in this same paradigm (Markus et al., 2002b). vated by phosphorylation (GSK-3 S9A). Neurons ex-
Taken together, these results suggest that localized acti- pressing the mutant GSK-3 had significantly shorter
vation of PI3K at the distal axon is important for efficient axons than control neurons expressing EGFP (Figure
axon elongation induced by NGF. 2F), indicating that GSK-3must be inactivated to allow
A downstream target of PI3K with potential to regulate efficient axon elongation. However, inactivation of GSK-
microtubules is GSK-3. To test whether PI3K regulates 3 with a kinase inhibitor or via activation of Wnt signal-
GSK-3 activity in E-13 mouse DRG neurons, we de- ing has also been shown to inhibit neurotrophin-induced
tected GSK-3 phosphorylation by Western blotting. axon extension (Krylova et al., 2002), suggesting that
GSK-3 is constitutively active in resting cells. Upon uniform inactivation of GSK-3 also impedes efficient
growth factor stimulation, it is inactivated via phosphor- axon elongation. To further test this idea, we transfected
ylation of its serine 9 residue (Sutherland et al., 1993). neurons with a construct encoding Frequently Re-
Addition of the PI3K inhibitor LY294002 to DRG neurons arranged in Advanced T cell Lymphomas 1 (Frat-1).
in the presence of NGF reduced phosphorylation of Frat-1 is an endogenous GSK-3 inhibitor that blocks
GSK-3 at ser9 in a dose-dependent manner (Figure GSK-3 activity toward selected targets in the Wnt path-
2A). Addition of a different PI3K inhibitor, wortmannin, way, such as axin, APC, and -catenin (Thomas et al.,
also led to a reduction in GSK-3 phosphorylation. 1999). Immunostaining showed that the expressed
These results are consistent with findings from a previ- Frat-1 was evenly distributed along the whole axon
ous study using embryonic chicken DRG neurons (Eick- shaft, suggesting uniform interaction between Frat-1
holt et al., 2002). Specificity of these results was demon- and GSK-3 along the length of the axon (Figure 2E).
strated by the fact that inhibition of ERK with inhibitor Neurons expressing Frat-1 had much shorter axons
U0126 had no effect (data not shown). A decrease in compared with EGFP-expressing neurons (Figure 2F).
GSK-3 phosphorylation was also seen after anti-NGF Interestingly, Frat-1 expression also led to a 2.6-fold
antibody treatment (data not shown). Moreover, readdi- increase in the axon branching frequency (EGFP, 5.0 
tion of NGF to NGF-starved DRG cultures induced dra- 0.31  103 branch points/m; Frat-1, 13.4  0.38 
matic increases in GSK-3 phosphorylation. This in- 103 branch points/m, p  0.0001). Together, these
crease was antagonized by pretreatment of cells with results indicate that inactivation of GSK-3 is important
LY294002 (Figure 2B). Together, these data demonstrate for efficient axon elongation and that GSK-3 inactiva-
that NGF regulates GSK-3 activity via PI3K in embry- tion must be spatially localized to the distal axon and
onic mouse DRG neurons.
the growth cone.
Downstream of PI3K, several kinases are candidates
for mediating the phosphorylation of GSK-3, including
NGF Regulates Microtubule Levels at the DistalAkt (Cross et al., 1995), ILK (Mills et al., 2003), and PKC
Axon via the PI3K-GSK-3 Pathway(Kanzaki et al., 2004). In PC12 cells, it has been shown
The results from the preceding sections suggest thatthat ILK phosphorylates GSK-3 downstream of NGF
the PI3K-GSK-3 pathway mediates NGF-induced axonand PI3K. Furthermore, ILK localizes to growth cones
growth. This mediation of axon growth presumably in-and is required for NGF-induced axon growth from DRG
volves the regulation of axonal microtubules. To directlyneurons (Mills et al., 2003). We therefore investigated the
visualize microtubule polymers in axons, we extractedrole of ILK in mediating NGF-induced phosphorylation
and fixed the neurons at the same time to eliminateof GSK-3 in DRG neurons. Addition of a specific ILK
tubulin monomers (as described by He et al., 2002) andinhibitor significantly blocked GSK-3 phosphorylation
then stained for polymerized microtubules. Under con-(Figure 2C), indicating that ILK acts downstream of PI3K
trol conditions, in the presence of NGF, polymerizedin embryonic mouse DRG neurons to regulate GSK-
microtubules showed a distribution gradient along the3 activity.
axon, with higher density at the distal end (Figure 3A1).We next examined the spatial distribution of GSK-3
Treatment of neurons with the microtubule-stabilizingactivity by staining axons with an antibody recognizing
drug taxol markedly increased the density of polymer-ser9 phosphorylated GSK-3. The result showed that
ized microtubules in the distal region as expected (Fig-phospho-GSK-3 (inactive GSK-3) was concentrated
ure 3A2). In contrast, the microtubule depolymerizingat the distal end of the axon (Figure 2D), spatially well
correlated with phospho-Akt (representing active PI3K) drug nocodozole almost eliminated polymerized micro-
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Figure 2. Regulation of GSK-3 by the NGF-
PI3K Pathway
(A) Western blot analysis showed that GSK-
3 was regulated by PI3K in cultures of E-13
DRG neurons. Treatment of neurons with ei-
ther LY294002 or wortmannin decreased the
amount of phosphorylated GSK-3 in a dose-
dependent manner. Similar results were ob-
tained in each of three independent experi-
ments.
(B) Readdition of NGF to NGF-starved cul-
tures markedly increased the phosphoryla-
tion of GSK-3. This effect was antagonized
by pretreatment with LY294002. A similar re-
sult was obtained in each of three indepen-
dent experiments.
(C) Treatment of neurons with a specific ILK
inhibitor, KP-074728 (ILKi), markedly decreased
the phosphorylation of GSK-3. Similar re-
sults were obtained in each of four indepen-
dent experiments.
(D) Similar to phospho-Akt, phosphorylated
GSK-3 was concentrated at the cell body
(stars) and the distal end of the axon (yellow
arrows), while little was detected along the
axon shaft (white arrowheads). High-magnifi-
cation images of the growth cone (bottom
panel) showed colocalization of pGSK-3
with actin. The scale bar represents 50 m in
the top panel and 10 m in the bottom panel.
(E) Overexpression of GSK-3 inhibiting pro-
tein Frat-1 blocked NGF-mediated axon growth.
Scale bar, 100 m.
(F) Quantification of the axon growth defect
in neurons expressing the active GSK-3mu-
tant GSK-3(S9A) and the GSK-3 inhibitor
Frat-1 compared to control neurons express-
ing EGFP (40 to 80 neurons in each of 3 to 6
independent experiments were analyzed in
each condition). * Indicates significant differ-
ence from the control (p  0.0001).
tubules, especially at the axon distal ends (Figure 3A3). GSK-3 inhibitor treatment alone increased the distal
microtubule level. These results suggest that inhibitionTherefore, this fix/extraction technique is able to detect
changes in microtubule levels. of GSK-3 activity positively regulates microtubule lev-
els downstream of the NGF-PI3K pathway. QuantitationUsing this method, we next asked how inhibition of
NGF signaling affects microtubule levels in the axons. of microtubule levels confirmed highly-significant ef-
fects of the NGF-PI3K-GSK-3 pathway in regulatingTreatment with an anti-NGF antibody significantly re-
duced the density of polymerized microtubules at the axonal microtubules (Figure 3B).
In the axons of control NGF-stimulated neurons, axondistal ends (Figure 3A5). A similar reduction in microtu-
bule levels was observed in neurons treated with the branching rarely occurs along the axon shaft (Figure
3C). In contrast, treatment of the axon with GSK-3PI3K inhibitor LY294002 (Figure 3A7), indicating the reg-
ulatory role of the NGF-PI3K pathway in axonal microtu- inhibitors induced axon branching along the entire axon
shaft (Figure 3C), indicating de novo microtubule assem-bules. As a control, neurons were also treated with jas-
plakinolide, an F-actin stabilizer that has been shown bly. This result suggests that GSK-3 inhibition plays
an important role in promoting microtubule assembly.to cause axon retraction via increased actomyosin inter-
action without significant microtubule depolymerization
(Gallo et al., 2002). In contrast to anti-NGF- or LY294002- Localization of APC Protein at the Microtubule
Plus Ends in Growing Axonstreated neurons, retracted axons of these neurons ex-
hibited high microtubule density at their distal ends One downstream target of GSK-3 that is a potential
regulator of axon microtubule assembly is APC. To local-(Figure 3A4). We next examined whether GSK-3 was
involved in mediating NGF-PI3K regulation of microtu- ize APC in axons of embryonic DRG neurons, we stained
the axons with an antibody recognizing the C terminusbules. Neurons treated with a specific GSK-3 inhibitor
(GSK-3 inhibitor I) were sensitive to neither anti-NGF (Mimori-Kiyosue et al., 2000b). As shown in Figure 4A1,
APC staining was intense in the soma and proximaltreatment nor PI3K inhibition in terms of microtubule
levels. They contained even higher microtubule density axon, tapered off along the distal axon, and then was
strikingly intense at the distal axon tip. Higher-magnifi-at their distal ends than that of control axons (Figures
3A6 and 3A8), which was consistent with the result that cation imaging showed that APC clustered at the very tip
GSK-3 and APC Mediate NGF-Induced Axon Growth
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Figure 3. NGF Regulates Axonal Microtubule Levels during Axon Growth through the PI3K-GSK-3 Pathway
(A) Neurons were fixed and extracted at the same time to eliminate free tubulin monomers. Images in the insets were pseudocolored to
indicate relative MT density at the distal axons. Red represents the highest fluorescent intensity and black indicates the lowest. In the control
condition, polymerized microtubules (MT) showed a proximal-distal gradient distribution (A1). Taxol treatment significantly increased MT
density, especially at the distal part of the axon (A2). Nocodazole treatment almost completely eliminated MT in the axon (A3). Retracted
axons induced by jasplakinolide showed elevated MT density at the distal region (A4). Treatment of neurons with either anti-NGF or LY294002
resulted in decreased MT density at the distal axon (A5 and A7). This effect was antagonized completely by pretreatment with a specific GSK-
3 inhibitor (A6 and A8).
(B) Quantification of relative MT density (compared to control axons) at the distal axon under each condition (n  3 independent experiments,
ANOVA, p  0.0001). *p  0.05, **p  0.001 (versus control), #p  0.0001 (between indicated groups).
(C) In control neurons, the axon shaft was smooth, indicating that MT were tightly bundled (C1). Inhibition of GSK-3 induced MT polymerization
and axon branching along the entire axon shaft (C2).
of the microtubule bundles (Figure 4A2). Microtubules in served APC distribution could have been due to cluster-
ing of APC at the membrane near the microtubule endsthese fast growing axons were highly bundled at their
distal ends, and individual microtubule filaments were rather than to direct binding of APC to the microtubules.
To confirm that APC binds to microtubule plus ends,difficult to resolve. Thus, it was possible that the ob-
Neuron
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Figure 4. Localization of the APC Protein in Axons and Growth Cones of Mouse DRG Neurons
(A) Double immunofluorescence staining for tubulin and APC. APC staining was most intense at the soma, proximal axon, and distal tip ([A1],
arrows). Higher-magnification imaging showed clustering of APC at the tip of the microtubule bundles ([A2], arrow). Axons treated with the
actin depolymerization drug cytochalasin E had splayed microtubules, where APC was clearly seen decorating the tips of the single microtubules
([A3], arrows). Scale bar, 50 m in (A1) and 16 m in (A2) and (A3).
(B) APC staining at the axon tip was retained after neurons were extracted with Triton X-100 before fixation to eliminate cytosolic proteins
([B1], arrow). Microtubules at the axon tip that colocalized with APC were more resistant to detergent extraction ([B2 and B3], arrows).
(C) Overexpression of Rac was used to expand growth cones to allow precise APC localization. Within the growth cone, APC was mainly
concentrated at the central domain, where most microtubules end (arrow). APC could also be observed in the actin-rich peripheral domain
(white arrowhead). Double staining of APC and tubulin showed that APC localized to the distal tips of individual microtubules ([C2], arrows
and inset) near the growth cone leading edge. Similar localization of APC at the microtubule tips was also observed in large control growth
cones (C3). Another microtubule plus end binding protein, EB1, had a similar distribution to that of APC inside the growth cone (C4). Double
staining showed that EB1 also localized at the tips of the single microtubules ([C5], arrows). As controls, EB1 was also present at the tips of
individual microtubules in the fibroblasts (C6). Scale bar, 10 m.
we treated neurons with cytochalasin to depolymerize tubules, neurons were extracted with 1% Triton X-100
before fixation. As expected, APC was shown to beactin filaments and therefore allow bundled microtu-
bules at the axon tips to splay apart. After cytochalasin Triton X-100 insoluble, indicating cytoskeleton binding
(Figures 4B1–4B3).treatment, APC protein could be resolved as clearly dec-
orating the tips of individual microtubules (Figure 4A3, To directly visualize APC localization in control neu-
rons without altering cytoskeletal structure, we trans-arrows). To further confirm that APC binds to the micro-
GSK-3 and APC Mediate NGF-Induced Axon Growth
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fected neurons with wild-type Rac to obtain larger APC accumulation compared to controls (Figure 5A).
Treatment with a function-blocking antibody againstgrowth cones. These large growth cones displayed nor-
NGF for 1 hr induced growth cone collapse and dramati-mal morphology and motility (data not shown) compared
cally diminished APC staining at the axon tips. This resultto the control growth cones. Microtubules in these Rac-
indicates a regulatory role of NGF in APC accumulation.expressing growth cones showed typical organization
Two different PI3K inhibitors, LY294002 and wortman-with most microtubules ending in the C domain and
nin, caused growth cone collapse with decreased fila-some individual dynamic microtubules protruding into
mentous actin and significantly reduced APC accumula-the P domain. As shown in Figure 4C1, APC protein was
tion. Similarly, the specific ILK inhibitor also inducedmainly concentrated in the C domain of the growth cone,
growth cone collapse and decreased APC accumula-where most microtubules end (arrow). Some APC was
tion. An ERK inhibitor, U0126, however, had little effectalso observed in the peripheral actin-rich region (arrow-
on APC staining even though it induced similar growthhead). Double staining for APC and tubulin revealed that
cone collapse. Thus, ERK activation is not necessarysome APC was clearly detected at the ends of individual
for APC accumulation. This result also indicates thatdynamic microtubules (Figure 4C2, arrows and inset).
changes in actin organization (growth cone collapse)This observation is consistent with previous studies in
per se do not affect APC-microtubule interactions. Thisnonneuronal cells (Mimori-Kiyosue et al., 2000a) and
lack of dependence of APC accumulation on actin poly-indicates that APC indeed binds to the plus ends of
merization was confirmed by the result that the actin
microtubules in axons. Similar APC localization was also
depolymerization reagent cytochalasin also had little ef-
observed in large growth cones of neurons without Rac
fect on APC accumulation at the axon tips. All of these
overexpression (Figure 4C3). results are quantified in Figure 5B. Together, these re-
EB1 is another microtubule plus end binding protein sults demonstrate that accumulation of APC at the mi-
that has been localized in axons (reviewed by Mimori- crotubule plus ends in axons is regulated by the PI3K-
Kiyosue and Tsukita, 2003). When EB1 was stained in ILK pathway downstream of NGF.
axons of DRG neurons, the protein showed a gradient In nonneuronal cells, APC-microtubule interactions
distribution with higher intensity at the distal end (Sup- are regulated by phosphorylation. GSK-3 has been
plemental Figure S2 at http://www.neuron.org/cgi/ shown to phosphorylate APC and abolish its ability to
content/full/42/6/897/DC1). Higher-magnification im- bind to microtubules (Zumbrunn et al., 2001). As a result,
aging showed comet-like structures along the distal part diminished APC accumulation upon PI3K inhibition in
of the axon (Supplemental Figure S2). The distribution axons could be due to the activation of GSK-3. We
of EB1 was different from the distribution of APC. EB1 therefore asked whether GSK-3 mediates the effect of
distributes evenly along the distal region of the axon PI3K in regulating APC-microtubule plus end associ-
(Supplemental Figure S2), while APC accumulates at the ation in axons. Treatment of neurons with a specific
very distal tip. In Rac-expressing neurons, EB1 had a GSK-3 inhibitor completely prevented the loss of APC
similar distribution in the growth cone central domain accumulation induced by the anti-NGF antibody, PI3K
to that of APC (Figures 4C4 and 4C5). As controls, fibro- inhibitors, and the ILK inhibitor (Figures 5A and 5B),
indicating that GSK-3 inhibition acts downstream ofblasts in the same culture dish as DRG neurons were
the NGF-PI3K-ILK pathway to mediate APC-microtubulealso examined for APC and EB1 staining. EB1 decorated
interactions. Interestingly, GSK-3 inhibition did not fullythe tips of all the polymerizing microtubules (Figure 4C6),
rescue the growth cone collapsing effects of the NGF-while APC was not detected at the microtubule plus
PI3K pathway inhibitors, suggesting that GSK-3 mayends of fibroblasts (data not shown).
not mediate PI3K-dependent actin organization, whichIn nonneuronal cells, APC has been shown to bind to
is also necessary for NGF-induced axon growth.actin filaments as well as microtubules (Rosin-Arbesfeld
As shown in the preceding section, APC accumulationet al., 2001). Double immunostaining of actin and APC
is mainly concentrated at the axon tips where GSK-3in growth cones revealed that APC decorating the tips
is inactivated and is absent in the axon shaft whereof dynamic microtubules tracked along actin bundles
GSK-3 is active. When neurons were treated with GSK-(Supplemental Figure S3A at http://www.neuron.org/
3 inhibitors (lithium and GSK-3 inhibitor I) to directlycgi/content/full/42/6/897/DC1). This finding suggests
inactivate GSK-3 along the entire length of the shaft,APC as a potential mediator for interactions between
APC accumulation was observed along the entire length
dynamic microtubules and actin bundles (Zhou et al.,
of the axon (Figure 5C). Moreover, this increased accu-
2002). Moreover, overexpressed C-terminal fragment of mulation of APC along the axon shaft upon GSK-3
APC, C-APCMTB, which contains the EB1 binding mo- inhibition was well correlated with increased microtu-
tif and a putative PDZ binding domain, specifically accu- bule polymerization as shown above (Figure 5D). All of
mulated as bundles in the peripheral domain of the these results are consistent with the idea that inhibition
growth cone where actin filaments are enriched (Supple- of GSK-3 promotes microtubule assembly via increas-
mental Figure S3B). ing APC-microtubule interactions. Moreover, applica-
tion of the GSK-3 inhibitor on axons separated from
the cell bodies showed similar APC accumulation and
Regulation of APC-Microtubule Interactions microtubule assembly along the axon shafts, demon-
by the NGF-PI3K-GSK-3 Pathway strating that a local signaling cascade in the axon medi-
To ask whether NGF-PI3K-GSK-3 signaling regulates ates these effects (Supplemental Figure S4).
the APC-microtubule interaction at the axon tip, we Previous studies in nonneuronal cells have suggested
that phosphorylation of GSK-3 via the PI3K pathwaytested the effects of various NGF signaling inhibitors on
Neuron
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Figure 5. Regulation of APC-Microtubule Interactions by the NGF-PI3K-GSK-3 Pathway
(A) In control growth cones, APC accumulation was concentrated in the central domain. Actin depolymerization with cytochalasin E (CE) did
not induce loss of APC staining. Treatment with anti-NGF caused growth cone collapse and eliminated the central domain APC accumulation.
Two different PI3K inhibitors, LY294002 (LY) and wortmannin (WT), each induced similar growth cone collapse and loss of APC accumulation.
A specific ILK inhibitor, KP-074728, also induced growth cone collapse and loss of APC accumulation. A specific ERK inhibitor, U0126, had
little effect on APC accumulation even though it collapsed growth cone. Pretreatment of neurons with a specific GSK-3 inhibitor (GSKi)
completely antagonized the effects of anti-NGF, LY, WT, and ILK inhibitor on APC accumulation. Scale bar, 10 m.
(B) Quantification of APC accumulation at the axon tips (n 	 3 independent experiments, ANOVA, p  0.0001). * Represents a significant
difference from control (p  0.0001); ** represents p  0.01; # represents a significant difference between indicated groups (p  0.0001).
(C) In the control axon, APC accumulation was mainly detected at the tip of the axon (arrowhead), while little was observed in the axon shaft.
Treatment with a GSK-3 inhibitor led to increased accumulation of APC along the axon shaft (arrowheads).
(D) In axons treated with a GSK-3 inhibitor, microtubule protrusions (white) were spatially correlated with APC accumulation (red) longitudinally
along the axon. Note that the APC accumulations were also correlated with the direction of the microtubule protrusions transversally across
the axon (arrows).
GSK-3 and APC Mediate NGF-Induced Axon Growth
905
fused to EGFP (Figure 7A). We first looked at the localiza-
tion of these APC mutants in DRG neurons. N-terminal
APC (N-APC) lacking the C-terminal microtubule and
EB1 binding domains was only observed in the cell bod-
ies and at the distal ends of the axon in the form of large
aggregates (Figure 7B1). Higher-magnification imaging
showed that the N-APC aggregates did not colocalize
with individual microtubule plus ends (Figure 7B1, inset).
This result indicates that the C-terminal microtubule
binding domains of APC are not required for the antero-
grade transport of the APC protein along microtubules.
Transport presumably occurs through binding to the
motor protein kinesin via the N-terminal armadillo do-
main (Jimbo et al., 2002). Since N-APC also contains
an oligomerization domain, overexpression of N-APC
should therefore bind to the endogenous APC and inter-
fere with its binding to the microtubules.
In contrast, C-terminal APC (C-APC) retaining both
microtubule and EB1 binding domains but lacking other
domains in the molecule was evenly distributed along
the whole axon shaft (Figure 7B2). Moreover, there was
no accumulation of C-APC at the distal end of the axon.
C-terminal APC lacking the microtubule binding domain
(C-APCMTB) can still bind to microtubules indirectly
through an interaction with EB1 (Mimori-Kiyosue et al.,
Figure 6. Regulation of -Catenin by the NGF-PI3K Pathway 2000b). Expression of this construct showed a similar
(A) Inhibition of PI3K activity with LY294002 or wortmannin induced distal-proximal distribution along the axon to that of EB1
significant decreases of total -catenin protein level in axonal prepa- (Figure 7B3 versus Supplemental Figure S2 at http://
rations. Similar results were obtained from three independent exper- www.neuron.org/cgi/content/full/42/6/897/DC1).
iments.
Thus, C-APCMTB accumulated at the distal ends of(B) Withdrawal of NGF with anti-NGF antibody induced decreases
the axons (Figure 7B3).of -catenin protein in axons.
Analysis of axon growth showed that both N-APC and(C) Immunostaining showed localization of -catenin at the tip of
the axon (in the central domain of the growth cone, yellow arrows). C-APC significantly retarded axon elongation induced
by NGF (Figures 7D and 7E). Immunostaining with an
antibody recognizing C-terminal APC revealed that en-
dogenous APC was indeed associated with N-APC ag-does not affect the -catenin/APC complex in the Wnt
gregates (Supplemental Figure S5A at http://www.pathway (see Cohen and Frame, 2001, for a review).
neuron.org/cgi/content/full/42/6/897/DC1) and there-However, more recently, phosphorylation of GSK-3 by
fore presumably was prevented from binding to thePKC
 was shown to cause APC localization at microtu-
microtubules and functioning properly. In contrast,bule plus ends in migrating astrocytes (Etienne-Manne-
C-APCMTB had little effect on axon growth (Figuresville and Hall, 2003). To confirm that the NGF-PI3K path-
7D and 7E), probably because spatially distributedway can access the -catenin/APC complex in axons,
C-APCMTB by itself could stabilize microtubules to-we collected axons from cultured DRG neurons after
gether with endogenous EB1 protein (Nakamura et al.,anti-NGF antibody or PI3K inhibitor treatment. The re-
2001). Our results are consistent with results reported
sults showed that both PI3K inhibitors and anti-NGF
by Green and Kaplan (2003). In that study, N-APC mutant
antibody induced loss of -catenin protein in axons, protein similar to the one used here disrupted spindle
likely due to activation of GSK-3 (Figures 6A and 6B). microtubules during mitosis, while C-APCMTB had
These results suggest that PI3K activation and GSK-3 no effect.
phosphorylation protect -catenin degradation in ax- To further confirm the functional role of APC in regulat-
ons. Indeed, in growing axons, -catenin is mainly con- ing axon growth, we generated a construct encoding
centrated at the tip of the axon, where GSK-3 is inacti- the C-terminal fragment of EB1 (C-EB1), which lacks the
vated and APC accumulates (Figure 6C). Similar microtubule binding domain but retains APC binding
colocalization of -catenin and APC at axon tips has ability (Bu and Su, 2003). Overexpression of C-EB1
been reported in cultured cortical neurons (Morrison et should therefore sequester endogenous APC and block
al., 1997). Together, our results establish that GSK-3 its function. In support of this idea, Expressed C-EB1
regulated by NGF-PI3K can influence -catenin/APC. was observed as large aggregates distributed along the
axon (Figure 7C1) and colocalized with endogenous APC
(Supplemental Figure S5B at http://www.neuron.org/
Spatial Localization of APC at Distal Tips Is cgi/content/full/42/6/897/DC1). We therefore tested
Necessary for Axon Growth Induced by NGF C-EB1 in our axon growth assay. The result showed that
To investigate the function of APC in regulating NGF- expression of C-EB1 in DRG neurons markedly inhibited
induced axon growth, we constructed a series of vectors axon growth in the presence of NGF (Figures 7D and
7F). As a control, we made another C-EB1 constructexpressing different functional domains of the protein
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Figure 7. Functional Analysis of APC in Reg-
ulating NGF-Mediated Axon Elongation
(A) Schematic diagrams of the domain organi-
zation of APC and the three truncated mutant
constructs used in the study.
(B) Localization of APC mutant proteins in the
axon. N-APC (without microtubule binding
domains) was mainly localized at the axon
distal end ([B1], arrow) in the form of discrete
aggregates (inset, white arrows) that did not
bind to individual microtubule (red) tips. Ex-
pressed EGFP-C-APC distributed evenly
along the axon without clear accumulation at
the tip ([B2], arrow head). C-APC containing
the EB1 binding domain but lacking the basic
domain (EGFP-C-APCMTB) showed a gra-
dient distribution along the axon with axon tip
accumulation ([B3], arrow). Scale bar, 50 m.
(C) Localization of EB1 mutant proteins in the
axon. C-EB1 was distributed along the axon
as large aggregates ([C1], white arrows).
C-EB1APC distributed evenly along the
axon (C2).
(D) Expression of N-APC (D1), C-APC (D2),
and C-EB1 (D5) blocked axon growth com-
pared to untransfected neurons or neurons
expressing EGFP (D4). Expression of EGFP-
C-APCMTB had little effect on axon growth
(D3). Scale bar, 100 m.
(E) Quantification of effects of different APC
mutants on axon elongation (30 to 80 cells in
three or more independent experiments were
analyzed for each condition). * Indicates sig-
nificant difference from the control (p 
0.0001).
(F) Quantification of effects of two EB1 mu-
tants on axon growth. * Indicates significant
difference from the control (p  0.0001).
without the APC binding sequence (C-EB1APC). Ex- Potential Role of the GSK-3-APC Pathway
in Mediating Fast Axon Elongationpressed C-EB1APC distributed evenly along the axon
similar to EGFP (Figure 7C2), and it had little effect on In addition to mediating NGF-induced axon growth, PI3K
has been recently shown to be required for axon differ-axon growth (Figure 7F). Together, these results indicate
that sequestration of endogenous APC by C-EB1 blocks entiation in cultured hippocampal neurons. Shi et al.
(2003) have shown that PI3K is only activated at the tipNGF-induced axon growth.
PI3K may regulate axonal microtubules either through of the axon, which is the fastest growing neurite. In order
to assess GSK-3 activation in this setting, we stainedstabilizing polymerized microtubules or through directly
interfering with microtubule polymerization (the addition stage 3 hippocampal neurons with anti-phospho-GSK-
3 and showed that inactivated GSK-3 was concen-of tubulin monomers). To distinguish between the two
possibilities, we examined EB1 localization as a marker trated at the tip of the axon, well correlated with PI3K
activation (Figure 8A1). Strikingly, when APC was exam-for microtubule polymerization. Inhibition of PI3K with
wortmannin had little effect on EB1 distribution along ined in these neurons, it accumulated only at the tips
of the axon and not at the tips of dendrites (Figure 8A2).the axon (Supplemental Figure S2 at http://www.neuron.
org/cgi/content/full/42/6/897/DC1), indicating that micro- This result suggests that the GSK-3-APC pathway may
act downstream of PI3K and Par3/Par6/aPKC pathwaystubule polymerization per se was not impeded by PI3K
inhibition. This result also indicated that binding of EB1 in hippocampal neurons to regulate axon differentiation.
Another example of fast axon elongation is injury-to the microtubule plus ends did not depend on APC-
microtubule interaction, consistent with previous stud- induced regenerative axon growth exhibited by adult
peripheral neurons (Smith and Skene, 1997). We haveies (Mimori-Kiyosue et al., 2000b).
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Figure 9. A Proposed Model for the Local NGF Signaling that Medi-
ates Assembly of the Axonal Cytoskeleton
NGF activates PI3 kinase preferentially at the tip of the axon. Acti-
vated PI3K promotes actin polymerization at the growth cone lead-
ing edge via activation of the small GTPases Cdc42 and Rac. A
positive feedback mechanism similar to that in migrating cells may
underlie the spatial activation of PI3K at the axon tip in the face of
uniform NGF stimulation. Spatially activated PI3K also induces a
similarly localized inactivation of GSK-3 through ILK. Inactivation
of GSK-3 allows the dephosphorylated APC protein to bind to the
microtubule plus ends and therefore promotes microtubule assem-
bly. Finally, microtubule polymerization at the plus ends together
with APC may also affect actin dynamics through binding of APC
to a Rac GTPase Exchange Factor (GEF), Asef.
Figure 8. Localization of pGSK-3 and APC in Neurons with Rapidly
APC. Our findings therefore demonstrate a novel path-Elongating Axons
way linking NGF signaling to a conserved cell polariza-(A) In embryonic hippocampal neurons, pGSk-3 was localized to
tion pathway that regulates microtubule dynamics at thethe distal tip of the axon (yellow arrow) but not to the tips of dendrites
growth cone. We suggest that NGF regulation of the([A1], white arrowheads). Accordingly, APC only accumulated at the
tip of the axon ([A2], yellow arrow). GSK-3-APC pathway at the growth cone underlies
(B) In mature regenerating DRG neurons, pGSK-3 was also local- the ability of NGF to instruct rapid axon growth (Figure
ized to the distal tip (B1), colocalizing with APC accumulation (B2). 9). We further suggest that this pathway affects microtu-
bule dynamics relatively independently of actin fila-
ments, which are often considered as the primary target
previously shown that such regenerative axon elonga- of extracellular signals in growth cones (see Huber et
tion is NGF and PI3K independent (Liu and Snider, 2001). al., 2003, for a review).
When axons of these regenerating neurons were exam-
ined, inactivation of GSK-3 and accumulation of APC Spatial Regulation of the PI3K-GSK-3 Pathway
were observed at the axon tips similar to the situation by NGF Is Required for Efficient
in embryonic neurons (Figure 8B). Taken together, our Axon Elongation
findings suggest that the GSK-3-APC pathway may be In this study, we have demonstrated that appropriate
accessed in growth cones of multiple classes of neurons spatial localization of PI3K signaling is critical for effi-
and in DRG neurons by different upstream signaling cient NGF-induced axon extension. The importance of
pathways at different stages of development. The find- localized PI3K signaling has also been demonstrated
ings suggest that the GSK-3-APC pathway may be a during directed cell migration. For example, during che-
universal mediator in the control of microtubule assem- motaxis, PI3K is spatially activated at the leading edge
bly to achieve rapid axon growth. of the migrating cells (see Iijima et al., 2002, for a review).
Such polarized PI3K activation is correlated with local-
ized actin polymerization, and both are necessary forDiscussion
directed cell migration (Wang et al., 2002). Suppression
of PI3K activity with pharmacological inhibitors or domi-In this study, we have asked how NGF regulates axonal
microtubules to mediate axon elongation. We demon- nant-negative constructs significantly blocked cell mi-
gration (Chung et al., 2001). Furthermore, recent findingsstrate that PI3K activation downstream of NGF is local-
ized to the growth cone and leads to similarly localized have shown that cells expressing a membrane-targeted
active PI3K or cells lacking the phosphatase PTEN thatinactivation of GSK-3. The localized GSK-3 inactiva-
tion at the growth cone then promotes efficient axon have unregulated PI3K activity also exhibited impaired
migration upon chemoattractant stimulation (Funamotoelongation via increasing the interactions between mi-
crotubules with the microtubule plus end binding protein et al., 2002). How this localized PI3K activity is generated
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in axons in the presence of global NGF stimulation is APC microtubule binding is abolished when APC is
phosphorylated by GSK-3 (Zumbrunn et al., 2001). Weunclear. One possibility is the involvement of a positive
feedback loop involving PI3K signaling and actin (see show here that, in NGF-stimulated growing axons, APC
molecules are spatially concentrated at growth cones,Figure 9), as has been suggested to occur in neutrophils
during chemotaxis (Weiner et al., 2002). well correlated with the spatial distribution of GSK-3
inactivation. We therefore hypothesize that APC is partSimilar to the situation for PI3K, GSK-3 was mainly
inactivated at the growth cone, and indeed, inactive of the machinery that transduces spatially regulated
PI3K-GSK-3 signaling to localized microtubule as-GSK-3was almost perfectly colocalized with activated
PI3K in the presence of NGF. Although the role of GSK- sembly.
How does APC regulate axonal microtubules during3 in regulating NGF-mediated axon growth has not
previously been investigated, prior studies have identi- axon growth? Our results demonstrated that the loss of
APC accumulation by inhibition of PI3K did not affectfied GSK-3 as a downstream target of NGF-PI3K sig-
naling in chicken DRG neurons (Eickholt et al., 2002) microtubule polymerization per se because there were
no changes in EB1 staining, which acted as a markerand in PC12 cells (Mills et al., 2003). Our data showed
that, upon PI3K inhibition, some GSK-3 remained for microtubule polymerization (Morrison et al., 2002).
This result indicates that localized APC accumulationphosphorylated even though almost all Akt was inacti-
vated (Figure 2). This result suggests that, in primary at the distal axon may not be required for microtubule
polymerization (monomer addition). Thus the main func-neurons, Akt may not mediate GSK-3 inactivation by
PI3K as it does in other cell types (van Weeren et al., tion of APC at the growth cone may be to support micro-
tubule stability, a well-characterized function in nonneu-1998). Another downstream target of PI3K, ILK, has been
shown to phosphorylate GSK-3 downstream of NGF ronal cells (Zumbrunn et al., 2001). Indeed, several lines
of evidence in our study suggest that APC may play anand PI3K in PC12 cells (Mills et al., 2003). Indeed, when
ILK activity was inhibited, phosphorylation of GSK-3 important role in mediating microtubule-actin interac-
tions in neurons, which have been suggested as onewas markedly decreased (Figure 2C), indicating that ILK
acts downstream of PI3K to mediate GSK-3 inactiva- method of regulating microtubule stability in growth
cones (reviewed by Zhou and Cohan, 2004).tion in mouse DRG neurons.
It is important to emphasize that, in growing axons, MAP-1B and Tau are two other microtubule binding
proteins that can be phosphorylated by GSK-3. Inter-microtubule polymerization is also spatially regulated.
By comparing the amounts of polymerized microtubules estingly, MAP-1B phosphorylation by GSK-3 is said to
be independent of the serine 9 phosphorylation statusunder different experimental conditions, we found that
inhibition of PI3K led to decreased microtubule levels, of GSK-3 (Goold and Gordon-Weeks, 2001). NGF in-
creases GSK-3-mediated phosphorylation of MAP-1Ban effect that could be prevented by GSK-3 inhibition.
These results identify PI3K and GSK-3 as mediators of in PC12 cells and sympathetic ganglion neurons (Goold
and Gordon-Weeks, 2001). However, whether GSK-3NGF that regulate axonal microtubules in DRG neurons.
The regulatory effect of PI3K and GSK-3 on axonal is the main kinase that regulates MAP-1B/microtubule
interactions is unknown. Indeed, overexpression ofmicrotubule levels could be achieved through either af-
fecting microtubule assembly or microtubule stabiliza- GSK-3 in neuronal cell lines does not affect MAP-1B-
microtubule binding (Goold et al., 1999). The major func-tion. Taken together, our findings demonstrate that two
spatially coupled kinases are important in mediating tion of Tau is to bundle microtubules when it is dephos-
phorylated (Wagner et al., 1996), whereas in our studyNGF-induced axon elongation via the regulation of mi-
crotubules. inhibition of GSK-3 induced microtubule debundling
and polymerization along axon shafts. This result indi-
cates that Tau is also unlikely to be a main target of GSK-Functional Role of GSK-3-APC Signaling
3 in DRG neurons regulating microtubule assembly.in NGF-Induced Axon Growth
In addition to regulating axon growth, the GSK-3-Despite its potential importance, the question of how
APC pathway may also control axon guidance if it ismicrotubule binding proteins are regulated by neuro-
locally regulated by chemotropic or chemorepellanttrophin signaling cascades has not previously been ad-
molecules. Indeed, both semaphorin 3A and Rhodressed (see Dent and Gertler, 2003). In addition to mi-
GTPase have been shown to regulate GSK-3 activitycrotubule binding proteins that bundle and stabilize
(Eickholt et al., 2002; Sayas et al., 2002). It would not bemicrotubules, such as MAP-1B and Tau (see below),
surprising if these guidance-signaling mediators werethere is a more recently identified group of microtubule
shown to regulate local microtubule dynamics directlyplus end tracking proteins (TIPs) (reviewed by Car-
via APC.valho et al., 2003) that specifically bind to the polymeriz-
ing microtubule plus ends. These proteins regulate mi-
crotubule dynamics in nonneuronal cells during cell Cross-Talk between NGF Signaling and the
GSK-3-APC Pathway Locally in Axonspolarization processes (see Gundersen and Bretscher,
2003, for a review). In this study, we identify one of the We report here that the GSK-3-APC complex, normally
considered a component of the Wnt pathway, can beTIPs, APC, as a major microtubule binding protein that
transduces neurotrophin signaling to axonal microtu- accessed by neurotrophin signaling. Our result is thus
in conflict with the current view that GSK-3 in the Wntbule assembly. Our results demonstrate that APC binds
to the plus ends of individual microtubules in the growth complex appears to be insulated from signaling trig-
gered by receptor tyrosine kinases (see Cohen andcone, suggesting an important role in regulating micro-
tubule dynamics in neurons. It is well established that Frame, 2001, for a review). The evidence for separation
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of the pathways is that GSK-3 inhibited by insulin sig- GSK-3/ mice had no defect in Wnt signaling (Hoeflich
et al., 2000). These results suggest that the GSK-3 iso-naling does not result in -catenin accumulation and
that activation of Wnt signaling has no effect on glyco- forms may compensate for each other in some situations
but play distinct roles in others.gen synthase activity downstream of insulin signaling
(Ding et al., 2000). How this compartmentalization is Most APC mutations result in truncated proteins lack-
ing the C-terminal sequences that contain both theachieved and how broadly it applies is unclear. Interest-
ingly, a recently published study showed that a cell -catenin and the microtubule binding domains (re-
viewed by Fearnhead et al., 2001). Mice that are homozy-polarity signaling complex, cdc42-par3/6-aPKC, could
interact with the Wnt signaling pathway and regulate gous for such APC mutations often die at early embry-
onic stages, preventing an analysis of the in vivo functionastrocyte migration via GSK-3 phosphorylation at ser-
ine 9 and APC binding to microtubule plus ends in of APC in axon growth. Another potential confounding
factor in determining functions of APC in mouse geneticastrocytes (Etienne-Manneville and Hall, 2003). In addi-
tion, ILK, a downstream target of PI3K, has also been studies is the existence of an APC family member that
may compensate for the functions of APC. Indeed, ashown to regulate -catenin-Lef/Tcf-dependent tran-
scription (Novak et al., 1998), and PTEN, a negative nervous system-specific APC homolog, APC-L, has been
identified (Nakagawa et al., 1998) and has been shownregulator of the PI3K pathway, can also regulate -cat-
enin-Lef/Tcf-dependent transcription involving phos- to regulate microtubule organization through the micro-
tubule binding protein EB3 (Nakagawa et al., 2000). RT-phorylation of GSK-3 on serine 9 (Persad et al., 2001).
Our results provide evidence that NGF can also inter- PCR experiments have detected high-level expression
of ALC-L in mouse DRG neurons (data not shown). Con-act with Wnt downstream mediators and regulate APC
phosphorylation through PI3K and ILK. The regulation sistent with this idea, two APC homologs in Drosophila,
APC1 and APC2, have been shown to play overlappingof APC in axons via GSK-3 phosphorlation induced by
PI3K signaling that we show here is similar in concept roles in regulating brain development (Akong et al.,
2002). Altogether, it seems likely that the generationto these two previous examples of regulation of APC
and -catenin by phosphorylation of GSK-3 at serine of mutant mice that are deficient in both APC family
members specifically in the nervous system will be re-9. Additional evidence for the cross-talk between NGF
signaling and Wnt mediators is provided by our finding quired to assess the role of APC proteins in regulating
axon morphogenesis in vivo.that withdrawal of NGF or inhibition of PI3K led to a
decreased level of -catenin protein in axons. Several
Experimental Proceduresrecent studies have documented roles for Wnt and
-catenin in axonal and dendritic branching (Krylova et
Materials
al., 2002; Yu and Malenka, 2003). It is very likely that A full list of pharmacological reagents, antibodies, and DNA con-
APC is involved in these processes via regulation of structs is provided in the Supplemental Data at http://www.
neuron.org/cgi/content/full/42/6/897/DC1.axonal microtubules. Based on our findings, it is tempt-
ing to hypothesize that Wnt and NGF may use the same
Gene Transfection and Pharmacologymachinery to control axon morphology. Through inhibi-
DRG neurons were transfected with various DNA constructs usingtion of GSK-3, both Wnt and NGF can promote APC-
a newly developed transfection technique from Amaxa (Cologne,
microtubule interactions and at the same time stabilize Germany). The transfection procedure was according to the Amaxa
-catenin. Thus, coordinated microtubule assembly me- protocols for mouse neurons. Briefly, dissociated neurons were
spun down to remove the supernatant completely and resuspendeddiated by APC and cell adhesion mediated by -catenin
in 100 l specified Amaxa electroporation buffer with 10–20 gmay regulate axon morphology. However, the final out-
plasmid DNA. Suspended cells were then transferred to a 2.0 mmcome (branching or elongation) is determined by the
cuvette and electroporated with an Amaxa Nucleofector apparatus.location of the signaling. NGF activates the GSK-
After electroporation, cells were immediately transferred to the de-
3-APC pathway at the distal axon and therefore pro- sired volume of culture medium and plated onto coated coverslips.
motes elongation, while Wnt activates it more proximally After neurons fully attached to the substrates (2–4 hr), the medium
was changed to remove the remnant transfection buffer. All thealong the axon and induces branching. This idea is in
pharmacological inhibitors were added directly to the neuronal cul-line with findings from a recent study in which Wnt sig-
ture medium at indicated concentration and duration after overnightnaling has been shown to act as an attractive axon
culture (20–24 hr). Cells were then fixed for further analysis. For eachguidance cue when it is presented as a distal-proximal
plasmid and pharmacological treatment, at least three independent
gradient (Lyuksyutova et al., 2003). experiments were conducted. Expression of N-APC and GSK-
3(S9A) frequently induced cell death. Therefore, we used neurons
from Bax null mice or cotransfected a Bcl2 cDNA together withImplications In Vivo
these constructs in the experiments.Although several mouse mutants have been generated
to address the roles of the GSK-3 and APC pathway,
Image Analysis and Statistics
there is no clear view of the role of these molecules All image analysis was done with Metamorph software. To measure
in vivo because of the possibility of “compensation” by axon length, the longest axon of each neuron was traced manually,
and the length was then calculated. For experiments with high trans-family members. There are two isoforms of GSK-3, 
fection efficiency (e.g., EGFP), about 50 neurons with axons wereand . GSK-3 null mice have been reported to die
selected in each experiment. To achieve random sampling, the cov-at about embryonic day 13, mainly due to hepatocyte
erslips (eight for each experiment) were scanned using the CCDapoptosis, or at P1 due to respiratory difficulties and
camera from the left to the right. The first 50 to 80 neurons encoun-
failure to feed (Hoeflich et al., 2000; Stankunas et al., tered that had identifiable axons were recorded. For low transfection
2003). However, before E-13 the GSK-3/ embryos efficiency constructs (e.g., N-APC), all identifiable positive neurons
with axons were selected for analysis.showed no morphological abnormality, and cells from
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To quantify the spatial distribution of Akt and GSK-3 activation, Atwal, J.K., Massie, B., Miller, F.D., and Kaplan, D.R. (2000). The
TrkB-Shc site signals neuronal survival and local axon growth vianeurons were stained with phospho-Akt and phospho-GSK-3, re-
spectively, as well as a fluorescent dye, DTAF, that stains total MEK and P13-kinase. Neuron 27, 265–277.
protein (Schindelholz and Reber, 1999). Because cold methanol fixa- Baas, P.W., and Luo, L. (2001). Signaling at the growth cone: the
tion disrupted the morphology of many growth cones in our culture, scientific progeny of Cajal meet in Madrid. Neuron 32, 981–984.
only ten neurons with positive pAkt staining from each experiment
Bhat, R.V., Baraban, J.M., Johnson, R.C., Eipper, B.A., and Mains,were selected for analysis. Twenty neurons with intact growth cones
R.E. (1994). High levels of expression of the tumor suppressor genewere chosen in each experiment for analysis of pGSK-3 staining
APC during development of the rat central nervous system. J. Neu-(which did not require methanol fixation). The growth cone and a
rosci. 14, 3059–3071.segment (about 50m) in the middle of the axon shaft were selected,
Brakeman, J.S., Gu, S.H., Wang, X.B., Dolin, G., and Baraban, J.M.and the average fluorescence intensity (AFI) of them from each
(1999). Neuronal localization of the Adenomatous polyposis coli tu-channel was measured. The ratio of Akt or GSK-3 staining at the
mor suppressor protein. Neuroscience 91, 661–672.axon shaft versus at the growth cone was calculated and then
normalized by the ratio of the DTAF staining. Bu, W., and Su, L.K. (2003). Characterization of functional domains
To quantify APC localization at the tips of the axons, neurons of human EB1 family proteins. J. Biol. Chem. 278, 49721–49731.
were double stained with APC and phalloidin. In each independent
Campenot, R.B. (1982a). Development of sympathetic neurons in
experiment, 20 to 30 neurons from each experiment were selected
compartmentalized cultures. II. Local control of neurite survival by
and recorded at a 60magnification with a CCD camera. For control
nerve growth factor. Dev. Biol. 93, 13–21.
experiments, the first 20 to 30 single neurons with intact and bright
Campenot, R.B. (1982b). Development of sympathetic neurons ingrowth cones were selected. For experiments involving pharmaco-
compartmentalized cultures. I. Local control of neurite growth bylogical inhibitors that caused growth cone collapse, only neurons
nerve growth factor. Dev. Biol. 93, 1–12.with collapsed growth cones were chosen and recorded. A small
region was created manually at the APC channel to outline the axon Cantley, L.C. (2002). The phosphoinositide 3-kinase pathway. Sci-
tip, and the AFI of this region was measured. The AFI of three ence 296, 1655–1657.
randomly selected regions in the same image was also measured Carvalho, P., Tirnauer, J.S., and Pellman, D. (2003). Surfing on micro-
as background to obtain the adjusted AFI (AFIaxon tip  AFIbackground) of tubule ends. Trends Cell Biol. 13, 229–237.
APC staining. So that results from each independent experiment
Chung, C.Y., Potikyan, G., and Firtel, R.A. (2001). Control of cellcould be compared relative to one another, the mean of adjusted
polarity and chemotaxis by Akt/PKB and PI3 kinase through theAFI from different conditions in each independent experiment was
regulation of PAKa. Mol. Cell 7, 937–947.normalized by the control APC level and represented as a percent-
age value. Cohen, P., and Frame, S. (2001). The renaissance of GSK3. Nat.
Rev. Mol. Cell Biol. 2, 769–776.To quantify polymerized microtubules in the axon, neurons under
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